Patent · US Active

Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one

US9278925B2 · kind B2 · utility

1Cited by

0References

8Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Ningshu Liu · Berlin, DE
Kai Thede · Leverkusen, DE
Ursula Mönning · Mölln, DE
Arne Scholz · Berlin, DE
Christoph-Stephan Hilger · Berlin, DE
Ulf Bömer · Glienicke, DE
Reiner Fischer · Monheim, DE

Key dates

Filing date	Jul 31, 2012
Grant date	Mar 8, 2016
Priority date	—
Expiry date	Sep 15, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-ones, in particular for therapeutic purposes, to pharmaceutical compositions and to their use in therapy, in particular for the prophylaxis and therapy of neoplastic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.